Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about UCBJY
Recent news which mentions UCBJY
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
April 09, 2025
Tickers
ARGX
AZN
GILD
GSK
Tags
UCBJF
NVO
Market News
From
Benzinga
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
March 21, 2025
Tickers
AMGN
AZN
BIIB
BMY
Tags
Briefs
NVS
BMY
From
Benzinga
Europe-Based UCB's Bimzelx Data Reveals Sustained Skin Clearance In Inflammatory Skin Disorders
March 07, 2025
Tickers
NEWS
UCBJF
UCBJY
Tags
General
Benzinga
Top Stories
From
Benzinga
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
November 20, 2024
Tickers
BIIB
NEWS
UCBJF
UCBJY
Tags
News
Trading Ideas
Health Care
From
Benzinga
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
November 20, 2024
Tickers
NEWS
UCBJF
UCBJY
Tags
Top Stories
Benzinga
General
From
Benzinga
Biogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal Trial
September 24, 2024
Tickers
BIIB
NEWS
UCBJF
UCBJY
Tags
UCBJY
Biotech
Stories That Matter
From
Benzinga
Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage
September 10, 2024
Tickers
LBPH
NEWS
UCBJF
UCBJY
Tags
UCBJF
epilepsy
Briefs
From
Benzinga
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
August 29, 2024
Tickers
ARGX
JNJ
NEWS
UCBJF
Tags
Briefs
JNJ
UCBJF
From
Benzinga
Belgium-Based Pharma Firm UCB To Offload China Neurology, Allergy Business For $680M To Asset Management Companies
August 26, 2024
Tickers
NEWS
UCBJF
UCBJY
Tags
General
Benzinga
Biotech
From
Benzinga
There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target
January 02, 2024
Tickers
LBPH
NEWS
UCBJF
UCBJY
Tags
Benzinga
General
LBPH
From
Benzinga
Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst
September 28, 2023
Tickers
AZN
DNTH
SNY
UCBJF
Tags
UCBJY
Price Target
Initiation
From
Benzinga
Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts
August 31, 2023
Tickers
MLTX
SLRN
UCBJF
UCBJY
Tags
Analyst Ratings
General
Benzinga
From
Benzinga
FDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia Gravis in Adults
June 27, 2023
Tickers
ARGX
UCBJF
UCBJY
Tags
Market News
Briefs
UCBJF
From
Benzinga
Cantor On MoonLake Immunotherapeutics - Initiates On Inexpensive Valuation, Strong Catalyst Path
February 14, 2023
Tickers
MLTX
NVS
UCBJF
UCBJY
Tags
Analyst Color
Health Care
News
From
Benzinga
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More
May 30, 2022
Tickers
ABBV
ALPN
AUPH
BLCO
Tags
GNCA
BLCO
News
From
Benzinga
‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy
May 20, 2022
Tickers
BMY
FATE
IBB
JNJ
Tags
FATE
CAMOX
PFE
From
MarketWatch
UCB's Rare Childhood Epilepsy Drug Scores FDA Approval
March 28, 2022
Tickers
UCBJF
UCBJY
Tags
Briefs
UCBJY
UCBJF
From
Benzinga
Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane
February 08, 2022
Tickers
BIIB
UCBJF
UCBJY
Tags
Health Care
News
UCBJF
From
Benzinga
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
January 23, 2022
Tickers
ABT
CUE
DCPH
ETON
Tags
Market News
DCPH
VRTX
From
Benzinga
UCB's Bispecific Marks Phase 3 Win For Second Psoriatic Arthritis Study
January 21, 2022
Tickers
UCBJF
UCBJY
Tags
Benzinga
Health Care
General
From
Benzinga
ZGNX Stock: The $1.9B UCB Deal That Has Zogenix Shares Zooming Higher Today
January 19, 2022
Tickers
SOFI
SONY
UCBJY
ZGNX
Tags
SONY
Today's Market
Market News
From
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021
September 02, 2021
Tickers
ALKS
ASMB
BLDE
CATB
Tags
TCBI
Upgrades
Analyst Ratings
From
Benzinga
UCB Gets EU Approval For Bimekizumab In Psoriasis
August 25, 2021
Tickers
NVS
UCBJF
UCBJY
Tags
Benzinga
General
UCBJY
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2021
August 23, 2021
Tickers
ACVA
CADL
CHK
CLR
Tags
DUOL
MAPS
GXO
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 23, 2021
July 23, 2021
Tickers
ADVM
AGESY
AGFY
AHH
Tags
PLUG
OGN
MP
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 9, 2021
July 09, 2021
Tickers
ALGN
ARGO
ASLN
BMBL
Tags
GNTY
DB
GM
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.